NCT04541290View on ClinicalTrials.gov

Tacrolimus as Treatment of Breast Cancer-Related Lymphedema

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 22, 2020

Primary Completion Date

January 6, 2022

Study Completion Date

January 6, 2022

Conditions
Breast Cancer Lymphedema
Interventions
DRUG

Protopic 0.1 % Topical Ointment

Applied in a thin layer covering all of the arm including the armpit and hand once a day for six months

Trial Locations (1)

5000

Department of Plastic Surgery, Odense University Hospital, Odense

All Listed Sponsors
lead

Odense University Hospital

OTHER

NCT04541290 - Tacrolimus as Treatment of Breast Cancer-Related Lymphedema | Biotech Hunter | Biotech Hunter